Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B
Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B
Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B
Submitted by
moderatorj
on September 5, 2012 - 9:52pm
Source:
Yahoo/BusinessWire
News Tags:
Baxter
FDA
treatment
hemophilia
Headline:
Baxter Submits Application for FDA Approval of Recombinant Factor IX for the Treatment of Hemophilia B
Do Not Allow Advertisers to Use My Personal information
